CIMA LAB Diagnostics reaches 100,000 hematological genetic tests

CIMA LAB Diagnostics has analyzed 100,000 samples of patients with hematological tumors since its start-up in 1988 as laboratory of genetic diagnosis of School of Sciences of the University of Navarra. This center is the only private, non-profit center that is recognized as a center of reference letter for hematological genetic diagnostic techniques and has already provided its services to more than forty public and private hospitals, both nationally and internationally.

The team of professionals at CIMA LAB Diagnostics receives samples of leukemias and lymphomas, in addition to other pathologies, and performs an integrated genetic diagnosis using the most appropriate genetic techniques according to the hematological tumor subject . 

"Genetic diagnosis is an essential factor that the clinical specialist needs for the correct management of his patients, since the analysis of genetic markers provides relevant information not only for diagnosis, but also for prognosis and treatment," explains Dr. María José Calasanz, director of the Hematological Genetic Diagnosis Unit of CIMA LAB Diagnostics and professor of Genetics of the School de Ciencias.

With the genetic report that the clinician receives, he or she can adapt the therapy to the patient's risk or select a treatment directed at a molecular target. "Thanks to genetic markers we can study targeted therapies, which are the basis of personalized precision medicine," explains Dr. Calasanz, who adds that "in hematological tumors, this genetic analysis is also performed during the course of the disease to monitor the effectiveness of the assigned treatment and modulate the clinical management of the patient". 

The laboratories of CIMA LAB Diagnostics not only perform a healthcare task, but also participate in the research of hematological pathologies or solid tumors. "We work alongside other laboratories of research partners with whom we participate in national, international projects or clinical trials and we are also part of several national cooperative groups."

The Dr. Jesús San Migueldirector Clínica Universidad de Navarra underlines the importance of this subject of laboratories responding quickly and is especially pleased "to have professionals who are always focused on the needs of the patient". Dr. María José Calasanz extends her thanks for having reached 100,000 genetic analyses to all the professionals of the hematology laboratory of CIMA LAB Diagnostics and to the Hematology services of Spanish and international hospitals "who have trusted us all these years", concluding that "as up to now, we want to continue to be alert to new techniques and maintain the quality standards in response times, always thinking of the benefit of the patient".